GB0027551D0 - Anti-tumor compounds - Google Patents

Anti-tumor compounds

Info

Publication number
GB0027551D0
GB0027551D0 GBGB0027551.1A GB0027551A GB0027551D0 GB 0027551 D0 GB0027551 D0 GB 0027551D0 GB 0027551 A GB0027551 A GB 0027551A GB 0027551 D0 GB0027551 D0 GB 0027551D0
Authority
GB
United Kingdom
Prior art keywords
tumor compounds
tumor
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0027551.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Priority to GBGB0027551.1A priority Critical patent/GB0027551D0/en
Publication of GB0027551D0 publication Critical patent/GB0027551D0/en
Priority to PCT/EP2001/012815 priority patent/WO2002038591A1/en
Priority to AU2002216012A priority patent/AU2002216012A1/en
Priority to US10/036,111 priority patent/US20030055052A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0027551.1A 2000-11-10 2000-11-10 Anti-tumor compounds Ceased GB0027551D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0027551.1A GB0027551D0 (en) 2000-11-10 2000-11-10 Anti-tumor compounds
PCT/EP2001/012815 WO2002038591A1 (en) 2000-11-10 2001-11-06 Fap-activated anti-tumor compounds
AU2002216012A AU2002216012A1 (en) 2000-11-10 2001-11-06 Fap-activated anti-tumor compounds
US10/036,111 US20030055052A1 (en) 2000-11-10 2001-11-09 FAP-activated anti-tumor compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0027551.1A GB0027551D0 (en) 2000-11-10 2000-11-10 Anti-tumor compounds

Publications (1)

Publication Number Publication Date
GB0027551D0 true GB0027551D0 (en) 2000-12-27

Family

ID=9902982

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0027551.1A Ceased GB0027551D0 (en) 2000-11-10 2000-11-10 Anti-tumor compounds

Country Status (3)

Country Link
AU (1) AU2002216012A1 (en)
GB (1) GB0027551D0 (en)
WO (1) WO2002038591A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506494A (en) * 1995-10-18 2000-05-30 メルク エンド カンパニー インコーポレーテッド Complexes useful for treating benign prostatic hyperplasia
US6613879B1 (en) * 1999-05-14 2003-09-02 Boehringer Ingelheim Pharma Kg FAP-activated anti-tumour compounds

Also Published As

Publication number Publication date
WO2002038591A1 (en) 2002-05-16
AU2002216012A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
IL145798A0 (en) Fap-activated anti-tumor compounds
EP1349851A4 (en) Compounds
GB0019950D0 (en) Compounds
AU2405002A (en) Dehalogeno compounds
GB0027552D0 (en) Anti-tumor compounds
GB0027551D0 (en) Anti-tumor compounds
GB0027554D0 (en) Anti-tumor compounds
GB0007404D0 (en) Compounds
GB0005574D0 (en) Compounds
GB0019578D0 (en) Polysulphamated compounds
GB0015902D0 (en) Compounds
GB0015853D0 (en) Compounds
GB0015852D0 (en) Compounds
GB0014823D0 (en) Compounds
GB0014652D0 (en) Compounds
GB0014642D0 (en) Compounds
GB0014641D0 (en) Compounds
GB0009457D0 (en) Compounds
GB0008728D0 (en) Compounds
GB0008727D0 (en) Compounds
GB0007653D0 (en) Compounds
GB0003637D0 (en) Compounds
GB0020503D0 (en) Compounds
GB0006800D0 (en) Compounds
GB0006457D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)